Search Results for keywords:"National Center for Advancing Translational Sciences"

The National Center for Advancing Translational Sciences, part of the National Institutes of Health, announced a closed meeting for February 18, 2021. The meeting, taking place virtually, will review and evaluate grant applications related to rare diseases. It is closed to the public to protect confidential information, trade secrets, and private details of individuals connected to the applications. Contact details for Dr. Carol Lambert at the Office of Scientific Review are provided for further inquiries.

The National Center for Advancing Translational Sciences is holding a closed meeting to review grant applications on February 12, 2021. The meeting is closed to the public due to potential disclosure of confidential information and personal privacy concerns. It will take place virtually through the National Institutes of Health. Dr. Carol Lambert will serve as the Scientific Review Officer for this event.

The National Center for Advancing Translational Sciences will hold closed meetings to review grant applications for a special panel on April 3, 2025. The meetings are closed to the public to protect confidential business information and personal privacy. They will be held virtually from 10:30 a.m. to 3:00 p.m. The review process will be overseen by Ming Yan, Ph.D., at the National Institutes of Health in Bethesda, Maryland.

The National Institutes of Health's National Center for Advancing Translational Sciences has announced two upcoming meetings that will be closed to the public. These meetings are set to take place on April 8-9, 2025, and April 10-11, 2025, and will be held virtually. They will focus on reviewing and evaluating grant applications, discussing sensitive information that includes potential trade secrets and private personal data. The meetings' closed nature is to ensure privacy and confidentiality in dealing with proprietary and personal information.